系统超声引导下中心静脉置管的部位特异性并发症:基于3SITES研究的目标试验模拟
本研究利用3SITES数据集进行目标试验模拟,纳入3409根导管(股静脉1153、颈内静脉1267、锁骨下989),采用逆概率加权调整部位分配和超声引导的混杂因素,在假设普遍超声引导的反事实框架下比较各部位并发症。结果显示锁骨下部位主要复合终点(导管相关血流感染或症状性深静脉血栓的时间)发生率低于股静脉(P=0.02)和颈内静脉(P=0.001),颈内静脉与股静脉间无差异(P=0.97)。锁骨下较颈内静脉的导管相关血流感染显著更少(P=0.001),股静脉和颈内静脉无症状血栓更常见,主要机械并发症罕见且各部位无显著差异。结论支持在ICU优先选用锁骨下入路。
要点
- 在假设普遍实时超声引导下,锁骨下入路的导管相关血流感染或症状性深静脉血栓复合终点低于股静脉(P=0.02)和颈内静脉(P=0.001)。
- 颈内静脉与股静脉的主要复合终点无差异(P=0.97)。
- 锁骨下较颈内静脉的导管相关血流感染显著更少(P=0.001)。
- 股静脉和颈内静脉的无症状血栓更常见。
- 主要机械并发症罕见且各部位无显著差异。
适用人群与场景
- 重症监护病房中接受中心静脉导管置入的患者,数据来源于3SITES数据集。
研究设计与关键结果
- 研究类型为目标试验模拟,使用3SITES数据集,共纳入3409根导管:股静脉1153根、颈内静脉1267根、锁骨下989根。
- 采用逆概率加权调整部位分配和超声引导的混杂因素,在假设普遍超声引导的反事实框架下比较加权结局。
- 主要终点为导管相关血流感染或症状性深静脉血栓的复合时间终点:锁骨下发生率低于股静脉(P=0.02)和颈内静脉(P=0.001);颈内静脉与股静脉无差异(P=0.97)。
- 次要终点:导管相关血流感染锁骨下显著少于颈内静脉(P=0.001);无症状血栓股静脉和颈内静脉更常见;主要机械并发症罕见且各部位无显著差异。
证据类型、等级与局限
- 证据类型为目标试验模拟(基于3SITES随机临床试验数据集)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在假设普遍实时超声引导下,锁骨下入路保留较低的感染和血栓风险且未观察到机械并发症增加,作者认为支持在重症监护病房优先使用锁骨下入路。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Central venous catheterization is the most common invasive procedure in intensive care units but remains burdened by infectious, thrombotic, and mechanical complications. Although real-time ultrasound guidance is now widely adopted, its effect on site-specific differences in overall complication rates has not been established. The 3SITES randomized clinical trial previously demonstrated lower infection and thrombosis rates with subclavian access but higher mechanical complications. However, as only a third of its procedures were ultrasound-guided in this study, these findings may not apply to current practice. The objective of the study was to compare complication rates across these three sites under a counterfactual framework assuming universal ultrasound guidance.
METHODS: This study was an emulated a target trial using the 3SITES dataset. Inverse probability weighting was applied to adjust for confounders of site assignment and ultrasound guidance. Weighted outcomes across catheter sites were compared under a counterfactual framework assuming universal ultrasound guidance. The primary outcome was a composite of time to catheter-related bloodstream infection or symptomatic deep-vein thrombosis. Secondary outcomes included each component separately, asymptomatic thrombosis, and major mechanical complications.
RESULTS: A total of 3409 catheters were included: 1153 in the femoral, 1267 in the internal jugular, and 989 in the subclavian site. Subclavian site showed a lower incidence of the primary outcome compared with femoral (P = .02) and jugular (P = .001) sites. The primary composite outcome did not differ between internal jugular and femoral sites (P = .97). Catheter-related bloodstream infections were significantly fewer with subclavian versus jugular access (P = .001). Asymptomatic thrombosis was more frequent at femoral and jugular sites. Major mechanical complications were rare and did not differ significantly across sites.
CONCLUSION: Assuming universal real-time ultrasound-guided central venous catheterization, subclavian access retains lower infectious and thrombotic risk without an observed increase in mechanical complications, supporting its preferential use in intensive care units.
参考来源
- Boulet N, Gavoille A, Iachkine J, et al. Site-specific complications of central venous catheterization under systematic ultrasound guidance: a target trial emulation revisiting the 3SITES study. Crit Care. 2025. PMID: 41331661. doi:10.1186/s13054-025-05747-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。